<html>
<head>PUBMED IDs for SIPL1</head>
<body bgcolor='#C5F0F2'><h1>SIPL1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/20458142/'>Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells.</a> June 22  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/24506958/'>[Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].</a> August 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25992689/'>Elevation of SIPL1 (SHARPIN) Increases Breast Cancer Risk.</a> April 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27941932/'>Sharpin promotes hepatocellular carcinoma progression via transactivation of Versican expression.</a> December 13  2016<br></body></html>
